April 25, 2011
I’ve posted about NASDAQ’s competing bid for NYSE and its possible risks. Seems that the NYSE board feels the same way, announcing: This proposal does not provide compelling value, has unacceptable execution risk and is therefore not in the best interests of NYSE Euronext shareholders. Ultimately, any litigation will turn on the “unacceptable execution risk” […]
Read the full article →
April 21, 2011
The Deal Professor examines another deal where management and the board put their own interests above shareholders. Despite Bankrate’s hasty and flawed sales process a couple of years ago, it’s now filing for an IPO. Specfically: The Bankrate board appeared to abdicate its responsibility to run a sale process that was open and without […]
Read the full article →